POPULARITY
59 episodes with kevin flanigan
2 episodes with kevin flanigan
Join us for a fantastic conversation with an expert in the field of neuromuscular disorders, Dr. Kevin Flanigan. Dr. Flanigan is the director of the Center for Gene Therapy at Nationwide Children's Hospitals, which developed the first FDA-approved gene therapy to treat Duchenne Muscular Dystrophy. He teaches us when to include muscular dystrophy in the differential, how BiPAP extends the lives of patients with Duchenne, and what the latest gene replacement therapies have to offer.
In this episode Lance and Joey interview Tomball Football Head Coach Kevin Flanigan about their upcoming playoff game against Bridgeland.
Culture is crucial to success. It's true in business, it's true in the family, and it's definitely true in the locker room. Culture is the soundbite encapsulating what the athletic program or team is really like to be a part of. It's what athletes say about their team to their non-athletic friends or their family. In this episode, we talk with Coach Kevin Flanigan, who explains that a program's culture is determined by it's leadership. If you want to have a great team culture, you've got to be a great leader. Key Takeaways: -Trust should be the foundation of your program. -The true value you place on something is the time you invest in it. -The leadership of a team dictates the culture, which dictates the behaviors, which dictates the results. To learn more about the 2Words Character Development Curriculum email Colton at colton@2words.tv or visit our website at www.2words.tv/gameplan.
Show from 6/19/20Wharton Finance Professor Jeremy Siegel, along with co-host Liqian Ren, kicks off the show with his weekly market update. He says we're headed for a modest, range bound market. He also mentions uncertainty regarding a second outbreak but for now explains that liquidity is still flowing into the markets. Then hosts Jeremy Schwartz and Kevin Flanigan talk to the Chief U.S. Economist at Morgan Stanley, Ellen Zenter, about their midyear outlook. According to Ellen, pent up demand will stimulate the economy as it reopens. She also compares the 2008 crisis to the COVID-19 epidemic saying that they are two very different situations and she expects a quicker recovery in today's economy.Guests:Ellen Zentner - Chief U.S. Economist for Morgan StanleyFollow Morgan Stanley on Twitter: @MorganStanleyFor more information on the Morgan Stanley's Midyear Outlook visit their website: https://www.morganstanley.com/To find out more about Ellen visit her profile page: https://www.morganstanley.com/profiles/ellen-zentner-chief-us-economistKevin Flanagan - Head of Fixed Income Strategy See acast.com/privacy for privacy and opt-out information.
Welcome back everyone to another week of VYPE Locker Talk Radio today is February 1sr which means its district realignment day. Every 2 years the University Interscholastic League redraws every district based on enrollment and geographic area. VYPE Magazine was down at the Region 4 Education Service Center in Houston to follow all the district announcements that began at 9am. Todd and Josh will break down the most interesting districts that came out of today and later in the podcast they talk more coaching changes happening this week. In segment 2 we will bring in a host of interviews that Matt Malatesta conducted Thursday morning as we have six coaches that will talk about their respective new districts. Drew Svoboda of Klein Collins, Cedric Hardeman of Conroe, James Clancy of Klein Cain, Jason Glenn of Klein Oak, Kevin Flanigan of Tomball and Larry McRae of Clear Lake will all discuss their thoughts on realignment. Be sure to subscribe to the VYPE Locker Talk Radio podcast through any smartphone app such as iTunes, Stitcher, iHeart Radio and Spreaker Radio. Follow us on Twitter @LockerTalkRadio and @VYPEHouston. For the latest in high school sports news, events, and podcasts visit VYPEHouston.com.
Todd James and Adam Coleman breakdown week 3 playoff action and bring in Fort Bend Marshall Head Coach James Williams to discuss the Buffalos tremendous playoff win over A&M Consolidated. Todd and Adam also discuss the Charlie Strong firing and how this affects local recruiting with Texas, Texas A&M, and UofH. VYPE SETX editor Thomas Bingham joins the program in the fourth segment for his weekly Golden Triangle report. He talked about the weekend's top action, and the news surrounding Beaumont West Brook head coach Kevin Flanigan. Additionally, he talks about the coaching hires at Texas and LSU, and how they'll affect local recruiting. This podcast is brought to you by Athlete Training + Health, Texas Foot Surgeons, and Freddy's Frozen Custard and Steakburgers.
Guest: Jerry Mendell, MD, is Director of the Center for Gene Therapy in The Research Institute, Director of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, and Curran-Peters Chair of Pediatric Research at Nationwide Children’s Hospital. He is also an attending neurologist at Nationwide Children’s and a professor of pediatrics and neurology at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about the gene therapy trial for Becker Muscular Dystrophy.
Guest: Jerry Mendell, MD, is Director of the Center for Gene Therapy in The Research Institute, Director of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, and Curran-Peters Chair of Pediatric Research at Nationwide Children’s Hospital. He is also an attending neurologist at Nationwide Children’s and a professor of pediatrics and neurology at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about the gene therapy trial for Becker Muscular Dystrophy.
Guest Host: Scott Harper, PhD, is a principal investigator in the Center for Gene Therapy in The Research Institute at Nationwide Children’s Hospital. Guest: Kevin Flanigan, MD, principal investigator in the Center for Gene Therapy, is also an attending neurologist at Nationwide Children’s and professor of Pediatrics and Neurology at The Ohio State University College of Medicine. View the published abstract for this month’s featured research article. Learn more about the Flanigan Lab and their research.
Guest Host: Scott Harper, PhD, is a principal investigator in the Center for Gene Therapy in The Research Institute at Nationwide Children’s Hospital. Guest: Kevin Flanigan, MD, principal investigator in the Center for Gene Therapy, is also an attending neurologist at Nationwide Children’s and professor of Pediatrics and Neurology at The Ohio State University College of Medicine. View the published abstract for this month’s featured research article. Learn more about the Flanigan Lab and their research.
Guest: Louise Rodino-Klapac, PhD, is a principal investigator in the Center for Gene Therapy in The Research Institute at Nationwide Children’s Hospital. She is also an assistant professor in the Department of Pediatrics at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about Dr. Rodino-Klapac’s gene therapy research for muscular dystrophies.
Guest: Louise Rodino-Klapac, PhD, is a principal investigator in the Center for Gene Therapy in The Research Institute at Nationwide Children’s Hospital. She is also an assistant professor in the Department of Pediatrics at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about Dr. Rodino-Klapac’s gene therapy research for muscular dystrophies.
Guest: Scott Harper, PhD, is a principal investigator in the Center for Gene Therapy in The Research Institute and the Neuromuscular Disorders program at Nationwide Children’s Hospital. He is also a faculty member for the Child Neurology Residency program at Nationwide Children’s and an assistant professor in the Department of Pediatrics at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about Dr. Harper’s research on neuromuscular disorders.
Guest: Scott Harper, PhD, is a principal investigator in the Center for Gene Therapy in The Research Institute and the Neuromuscular Disorders program at Nationwide Children’s Hospital. He is also a faculty member for the Child Neurology Residency program at Nationwide Children’s and an assistant professor in the Department of Pediatrics at The Ohio State University College of Medicine. • View the published abstract for this month’s featured research article. • Learn more about Dr. Harper’s research on neuromuscular disorders.
Dr. Brian Kaspar Discusses a New Method for Studying ALS, with Potential to Test Therapeutics in Individual Patients :: April 2014 Guest: Brian Kaspar, PhD, is a principal investigator in the Center for Gene Therapy and the first recipient of the Grant Morrow, III, MD, Endowed Chair in Pediatric Research in The Research Institute at Nationwide Children’s Hospital. He is also an associate professor in the departments of Pediatrics and Neuroscience at The Ohio State University College of Medicine, and a recognized national expert in the discovery of new therapies for spinal muscular atrophy and amyotrophic lateral sclerosis.
Dr. Brian Kaspar Discusses a New Method for Studying ALS, with Potential to Test Therapeutics in Individual Patients :: April 2014 Guest: Brian Kaspar, PhD, is a principal investigator in the Center for Gene Therapy and the first recipient of the Grant Morrow, III, MD, Endowed Chair in Pediatric Research in The Research Institute at Nationwide Children’s Hospital. He is also an associate professor in the departments of Pediatrics and Neuroscience at The Ohio State University College of Medicine, and a recognized national expert in the discovery of new therapies for spinal muscular atrophy and amyotrophic lateral sclerosis.
Dr. Louis Chicoine Discusses the Effect of Plasmapheresis in Removal of AAV Antibodies for Gene Therapy :: November 2013 Guest: Louis Chicoine, MD, principal investigator in the Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital; assistant professor of Pediatrics at The Ohio State University College of Medicine. Access an abstract of this month’s featured research article: Plasmapheresis eliminates the negative impact of AAV antibodies on micro-dystrophin gene expression following vascular delivery. Molecular Therapy. 2013 Oct 23. [Epub ahead of print] Major contributors to the work described include the Jesse’s Journey Foundation, the Nationwide Children’s Hospital Foundation, the Muscular Dystrophy Association, a National Institutes of Health grant (U54 NS055958), and a Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (U54 HD066409).
Dr. Louis Chicoine Discusses the Effect of Plasmapheresis in Removal of AAV Antibodies for Gene Therapy :: November 2013 Guest: Louis Chicoine, MD, principal investigator in the Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital; assistant professor of Pediatrics at The Ohio State University College of Medicine. Access an abstract of this month’s featured research article: Plasmapheresis eliminates the negative impact of AAV antibodies on micro-dystrophin gene expression following vascular delivery. Molecular Therapy. 2013 Oct 23. [Epub ahead of print] Major contributors to the work described include the Jesse’s Journey Foundation, the Nationwide Children’s Hospital Foundation, the Muscular Dystrophy Association, a National Institutes of Health grant (U54 NS055958), and a Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (U54 HD066409).
Dr. Volker Straub Discusses the Use of Muscle MRI in Muscular Dystrophy Guest: Volker Straub, MD, PhD, Harold Macmillan Professor of Medicine and Professor of neuromuscular genetics at the University of Newcastle upon Tyne in the United Kingdom. Access an abstract of this month’s featured research articles: - Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study. PLoS One. 2013 Aug 14, 8(8):e70993. - MR imaging in Duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months. Muscle Nerve. 2013 Apr 26.
Dr. Volker Straub Discusses the Use of Muscle MRI in Muscular Dystrophy Guest: Volker Straub, MD, PhD, Harold Macmillan Professor of Medicine and Professor of neuromuscular genetics at the University of Newcastle upon Tyne in the United Kingdom. Access an abstract of this month’s featured research articles: - Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study. PLoS One. 2013 Aug 14, 8(8):e70993. - MR imaging in Duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months. Muscle Nerve. 2013 Apr 26.
Dr. Jeff Chamberlain Discusses Gene and Cell Mediated Therapies for Muscular Dystrophy Guest: Jeff Chamberlain, PhD, McCaw Chair in Muscular Dystrophy and Professor in the departments of neurology, medicine and biochemistry at the University of Washington. Access an abstract of this month’s featured article: Gene and cell-mediated therapies for muscular dystrophy. Muscle Nerve. 2013 May, 47(5):649-63. Epub 2013 Mar 29.
Dr. Jeff Chamberlain Discusses Gene and Cell Mediated Therapies for Muscular Dystrophy Guest: Jeff Chamberlain, PhD, McCaw Chair in Muscular Dystrophy and Professor in the departments of neurology, medicine and biochemistry at the University of Washington. Access an abstract of this month’s featured article: Gene and cell-mediated therapies for muscular dystrophy. Muscle Nerve. 2013 May, 47(5):649-63. Epub 2013 Mar 29.
Dr. Louise Rodino-Klapac Discusses Alpha 7 Integrin As A Therapeutic Approach to Muscular Dystrophy Guest: Louise Rodino-Klapac, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital. Access an abstract of this month’s featured research article: AAV-mediated Overexpression of Human a7 Integrin Leads to Histological and Functional Improvement in Dystrophic Mice. Mol Ther. 2013 Mar;21(3):520-5. doi: 10.1038/mt.2012.281. Epub 2013 Jan 15.
Dr. Louise Rodino-Klapac Discusses Alpha 7 Integrin As A Therapeutic Approach to Muscular Dystrophy Guest: Louise Rodino-Klapac, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital. Access an abstract of this month’s featured research article: AAV-mediated Overexpression of Human a7 Integrin Leads to Histological and Functional Improvement in Dystrophic Mice. Mol Ther. 2013 Mar;21(3):520-5. doi: 10.1038/mt.2012.281. Epub 2013 Jan 15.
Dr. James Ervasti Discusses Stability of Therapeutic Forms of Dystrophin :: January 2013 Guest: Dr. James Ervasti, PhD, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Access an abstract of this month’s featured research article: Hum Mol Genet. 2011 Aug 1;20(15):2955-63. doi: 10.1093/hmg/ddr199. Epub 2011 May 10.
Dr. James Ervasti Discusses Stability of Therapeutic Forms of Dystrophin :: January 2013 Guest: Dr. James Ervasti, PhD, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Access an abstract of this month’s featured research article: Hum Mol Genet. 2011 Aug 1;20(15):2955-63. doi: 10.1093/hmg/ddr199. Epub 2011 May 10.
Dr. Federica Montanaro Discusses New Cardiac Dystrophin Associated Proteins :: December 2012 Guest: Dr. Federica Montanaro, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One. 2012;7(8):e43515.
Dr. Federica Montanaro Discusses New Cardiac Dystrophin Associated Proteins :: December 2012 Guest: Dr. Federica Montanaro, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One. 2012;7(8):e43515.
Professor Francesco Muntoni Discusses Congenital Muscular Dystrophies Guest: Professor Francesco Muntoni, Chair of Paediatric Neurology, United College London Institute of Child Health, Dubowitz Neuromuscular Centre Access an abstract of this month’s featured research article: The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol. 2012 Jul;72(1):9-17.
Professor Francesco Muntoni Discusses Congenital Muscular Dystrophies Guest: Professor Francesco Muntoni, Chair of Paediatric Neurology, United College London Institute of Child Health, Dubowitz Neuromuscular Centre Access an abstract of this month’s featured research article: The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol. 2012 Jul;72(1):9-17.
Dr. Louise Rodino-Klapac Discusses Advances in Dysferlin Gene Therapy Guest: Louise Rodino-Klapac, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer. PLoS One. 2012;7(6):e39233. Epub 2012 Jun 15.
Dr. Louise Rodino-Klapac Discusses Advances in Dysferlin Gene Therapy Guest: Louise Rodino-Klapac, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer. PLoS One. 2012;7(6):e39233. Epub 2012 Jun 15.
Dr. Hugh Allen Discusses Cardiomyopathy in Duchenne Muscular Dystrophy Guest: Hugh Allen, MD, principal investigator, Center for Gene Therapy Access an abstract of this month’s featured research article: Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy. Am J Cardiol. 2012 Mar 29.
Dr. Hugh Allen Discusses Cardiomyopathy in Duchenne Muscular Dystrophy Guest: Hugh Allen, MD, principal investigator, Center for Gene Therapy Access an abstract of this month’s featured research article: Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy. Am J Cardiol. 2012 Mar 29.
Dr. Jerry Mendell Discusses Newborn Screening in Duchenne Muscular Dystrophy :: April 2012 Guest: Jerry Mendell, MD, director, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital. Access an abstract of this month’s featured research article: Evidence-based path to newborn screening for duchenne muscular dystrophy. Ann Neurol. 2012 Mar;71(3):304-13.
Dr. Jerry Mendell Discusses Newborn Screening in Duchenne Muscular Dystrophy :: April 2012 Guest: Jerry Mendell, MD, director, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital. Access an abstract of this month’s featured research article: Evidence-based path to newborn screening for duchenne muscular dystrophy. Ann Neurol. 2012 Mar;71(3):304-13.
Dr. Thomas Voit Discusses Gamma Sarcoglycan Gene Therapy :: March 2012 Guest: Thomas Voit, medical and scientific director, Institut de Myologie, Paris, France Access an abstract of this month’s featured research article: A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain. 2012 Feb;135(Pt 2):483-92.
Dr. Thomas Voit Discusses Gamma Sarcoglycan Gene Therapy :: March 2012 Guest: Thomas Voit, medical and scientific director, Institut de Myologie, Paris, France Access an abstract of this month’s featured research article: A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain. 2012 Feb;135(Pt 2):483-92.
Dr. Arthur Burghes discusses antisense oligomer treatment in an SMA mouse model Guest: Arthur Burghes, PhD, professor of Molecular and Cellular Biochemistry, Molecular Genetics and Neurology, The Ohio State University
Dr. Arthur Burghes discusses antisense oligomer treatment in an SMA mouse model Guest: Arthur Burghes, PhD, professor of Molecular and Cellular Biochemistry, Molecular Genetics and Neurology, The Ohio State University
Guest: Denis Guttridge, PhD, Associate Professor, Molecular Virology, Immunology and Medical Genetics, The Ohio State University Access an abstract of this month’s featured research articles: Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy. J Transl Med. 2011 May 17;9:68. doi: 10.1186/1479-5876-9-68. Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Mol Med. 2011 May-Jun;17(5-6):508-15. doi: 10.2119/molmed.2010.00263.
Guest: Denis Guttridge, PhD, Associate Professor, Molecular Virology, Immunology and Medical Genetics, The Ohio State University Access an abstract of this month’s featured research articles: Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy. J Transl Med. 2011 May 17;9:68. doi: 10.1186/1479-5876-9-68. Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Mol Med. 2011 May-Jun;17(5-6):508-15. doi: 10.2119/molmed.2010.00263.
Guest: Jill Rafael-Fortney, PhD, Department of Molecular and Cellular Biochemistry, The Ohio State University Access an abstract of this month’s featured research article: Early Treatment with Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy Mice. Circulation. 2011 Aug 2;124(5):582-8.
Guest: Jill Rafael-Fortney, PhD, Department of Molecular and Cellular Biochemistry, The Ohio State University Access an abstract of this month’s featured research article: Early Treatment with Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy Mice. Circulation. 2011 Aug 2;124(5):582-8.
Guest: Dr. Carsten Bonnemann, MD, Senior Investigator, Neurogenetics Branch, and Chief of Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institutes of Neurological Disorders and Stroke, National Institutes of Health Access an abstract of this month's featured research article: Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. Ann Neurol. 2011 Jan;69(1):206-11.
Guest: Dr. Carsten Bonnemann, MD, Senior Investigator, Neurogenetics Branch, and Chief of Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institutes of Neurological Disorders and Stroke, National Institutes of Health Access an abstract of this month's featured research article: Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. Ann Neurol. 2011 Jan;69(1):206-11.
Guest: Paul Martin, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med. 2010 Jul 28;2(42):42ra54.
Guest: Paul Martin, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med. 2010 Jul 28;2(42):42ra54.
Guest: Scott Harper, PhD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol. 2010 Oct 28. [Epub ahead of print]
Guest: Scott Harper, PhD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol. 2010 Oct 28. [Epub ahead of print]
Guest: Jerry Mendell, MD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med. 2010 Oct 7;363(15):1429-37.
Guest: Jerry Mendell, MD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med. 2010 Oct 7;363(15):1429-37.
Guest: Dr. Craig McDonald, Chair and Professor of Physical Medicine and Rehabilitation and Professor of Pediatrics at UC Davis Access full-text versions of this Month's Featured Research Articles: The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010 Dec;42(6):966-74. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2010 Apr;41(4):500-10.
Guest: Dr. Craig McDonald, Chair and Professor of Physical Medicine and Rehabilitation and Professor of Pediatrics at UC Davis Access full-text versions of this Month's Featured Research Articles: The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010 Dec;42(6):966-74. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2010 Apr;41(4):500-10.
Guest: Dr. Annemieke Aartsma-Rus, DMD Genetic Therapy Group, Dept. of Human Genetics, Leiden University Medical Center, The Netherlands Access an abstract of this Month's Featured Research Article: Progress in therapeutic antisense applications for neuromuscular disorders. Eur J Hum Genet. 2010 Feb;18(2):146-53.
Guest: Dr. Annemieke Aartsma-Rus, DMD Genetic Therapy Group, Dept. of Human Genetics, Leiden University Medical Center, The Netherlands Access an abstract of this Month's Featured Research Article: Progress in therapeutic antisense applications for neuromuscular disorders. Eur J Hum Genet. 2010 Feb;18(2):146-53.
Guest: Federica Montanaro, PhD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Circ Cardiovasc Genet. 2009 Dec;2(6):544-51.
Guest: Federica Montanaro, PhD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Circ Cardiovasc Genet. 2009 Dec;2(6):544-51.
Guest: Professor Kate Bushby, joint coordinator of the TREAT-NMD network Access full-text versions of this Month's Featured Research Articles: The diagnosis and management of Duchenne muscular dystrophy Part 1: diagnosis, and pharmacological and psychosocial management; Part 2: implementation of multidisciplinary care View the Supplemental Family Guide: DMD guide for families
Guest: Professor Kate Bushby, joint coordinator of the TREAT-NMD network Access full-text versions of this Month's Featured Research Articles: The diagnosis and management of Duchenne muscular dystrophy Part 1: diagnosis, and pharmacological and psychosocial management; Part 2: implementation of multidisciplinary care View the Supplemental Family Guide: DMD guide for families
Guest: Brian Kaspar, PhD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol. 2010 Mar;28(3):271-4.
Guest: Brian Kaspar, PhD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol. 2010 Mar;28(3):271-4.
Guest: Jerry Mendell, MD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Sci Transl Med 11 November 2009: Vol. 1, Issue 6, p. 6ra15
Guest: Jerry Mendell, MD, Nationwide Children's Hospital Access an abstract of this Month's Featured Research Article: Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Sci Transl Med 11 November 2009: Vol. 1, Issue 6, p. 6ra15
© 2020-2025 Ivy Podcast Discovery LLC
